Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.

Breast cancer research and treatment - 1 Jun 2011

Darabi Hatef, Czene Kamila, Wedrén Sara, Li Yuqing, Liu Jianjun, Hall Per, Humphreys Keith

Abstract excerpt

Genetic variation in the androgen-to-estrogen conversion pathway has been shown to be associated with risk of breast cancer and, in particular, with estrogen receptor (ER) positive tumours. We aimed at studying how the genetic alterations, which have been identified for risk, are associated with breast cancer prognosticators, with a prior hypothesis that, in general, hormone-related breast cancers have a better...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Androgens
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Estrogens

Share to Genetic Variation

Share to Neoplasm Staging

Share to Prognosis

Source

Identifiers

PMID: 20960227
DOI: 10.1007/s10549-010-1218-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators.PMID 20960227Read ↗

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.Semantic proximity Read ↗

Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade.Semantic proximity Read ↗

The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.Semantic proximity Read ↗

Single- and multi-locus association tests incorporating phenotype heterogeneity.Semantic proximity Read ↗

CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.Semantic proximity Read ↗

Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer.Semantic proximity Read ↗

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.Semantic proximity Read ↗

Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Semantic proximity Read ↗

Association of variants in estrogen-related pathway genes with prostate cancer risk.Semantic proximity Read ↗

Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer.Semantic proximity Read ↗

Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.Semantic proximity Read ↗

Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.